Nomax Inc. is a specialty contract pharmaceutical company founded in 1982. The company's slogan, "Provide our customers with the highest quality products available, at fair prices, delivered with superior service," highlights its commitment to customer satisfaction. Nomax Inc. is focused on developing innovative niche pharmaceutical products for patients and other pharmaceutical companies, positioning itself as a leader in Rx and over-the-counter effervescent product manufacturing. The company is headquartered in the United States at 9735 Green Park Industrial Drive, St. Louis, MO 63123. Nomax Inc. has a strong foundation in the pharmaceutical industry, leveraging its expertise to offer high-quality products at fair prices. However, as of now, there is no specific information available regarding the last investment and the investors involved. Despite this, Nomax Inc.'s long-standing presence in the industry and its focus on innovation make it a potential candidate for future investments. In summary, Nomax Inc. has established itself as a reputable player in the pharmaceutical industry, with a focus on niche product development and superior service delivery. While the specifics of its recent investment activities are currently unavailable, the company's track record and commitment to quality position it as a noteworthy prospect for potential venture capital considerations.
There is no investment information
No recent news or press coverage available for Nomax Inc.